ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

Orchid Pharma Limited Complete list of announcements declared & dividend announcements by Orchid Pharma Limited ORCHPHARMA_BE

Orchid Pharma Limited ORCHPHARMA_BE listed on NSE and deals in

Announcements and dividends declared by Orchid Pharma Limited ORCHPHARMA_BE

Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
Orchid Pharma rallied 5.76% to Rs 1,217.20 after the company has received an approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Exblifep(Cefepime and Enmetazobactam injections).
Announcement as on 23 February 2024

Orchid Pharma receives USFDA approval for Enmetazobactam
Orchid Pharma has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, Enmetazobactam'. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (E
Announcement as on 23 February 2024

Orchid Pharma's new antibiotic 'Exblifeb' gets European Medicines Agency approval
The Chennai-based firm said Exblifeb incorporates Enmetazobactam, "the first completely invented-in-India Beta Lactamase inhibitor" and it is designed to address the global challenge of antimicrobial resistance (AMR). Exblifeb' demonstrates remarkable effi
Announcement as on 30 January 2024

Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
Chennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7ACA project under the production linked incentive (PLI) scheme. The deal will enable Orchid Bio Pharma to manufacture "
Announcement as on 11 July 2023

Orchid Pharma locked in upper circuit, QIP floor price set at Rs 425
Sources have told CNBC-TV18 that the base size for the issue is approximately Rs 300 crore, with an option to upsize up to Rs 400 crore
Announcement as on 23 June 2023

Announcements by Orchid Pharma Limited first page | Next page | Prev page |

ORCHPHARMA_BE Orchid Pharma Limited current price & indicator signals

Moving Averages for Orchid Pharma Limited

  • 5Day Average: 523.16
  • 12Day Average: 523.95
  • 20Day Average: 532.54
  • 50Day Average: 552.99
  • 100Day Average: 504.48
  • 150Day Average: 467.62
  • 200Day Average: 444.33

ORCHPHARMA_BE Indicators & signals

Indicator MACD (12,26,9)

527, 534.23, -7.94
Indicator MACD is in negative zone

Indicator ADX (14)

15.31, 14.37, 19.56
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ORCHPHARMA_BE Orchid Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Fri Sep 2023 531.80 516.20 to 546.00 0.73% 1.44 times
28 Thu Sep 2023 527.95 508.50 to 544.00 -1.36% 4.01 times
27 Wed Sep 2023 535.25 510.25 to 535.25 4.99% 5.2 times
26 Tue Sep 2023 509.80 508.00 to 523.00 -0.23% 0.09 times
25 Mon Sep 2023 511.00 510.00 to 524.00 0.1% 0.08 times
22 Fri Sep 2023 510.50 500.10 to 524.90 -1.43% 0.1 times
21 Thu Sep 2023 517.90 514.95 to 532.00 -1.34% 0.1 times
20 Wed Sep 2023 524.95 520.65 to 530.70 -0.51% 0.05 times
18 Mon Sep 2023 527.65 525.05 to 534.00 -1.11% 0.07 times
15 Fri Sep 2023 533.55 511.50 to 539.00 0.27% 0.1 times
14 Thu Sep 2023 532.10 525.00 to 541.90 1.35% 0.2 times
13 Wed Sep 2023 525.00 502.00 to 530.40 1.61% 0.22 times

Videos related to: ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ORCHPHARMA_BE announcements Orchid Pharma Limited announcements and dividends declared NSE

 

Back to top